Refine Search
(0)
(3)
(3)
(4)

Neurology

GlobalData provides unique and market-leading data and insights into the neurology market. Browse or search our Report Store for the latest comprehensive reports, market data, analysis and survey findings alongside industry information on key companies, markets and financial deals.

Digital Landscape: Multiple Sclerosis

  • $6,000
  • August 2018
Add to Basket Quick View Add to Saved List

The Digital Landscape Multiple Sclerosis report analyzes digital activities undertaken by Pharma in support of disease-modifying therapies for Multiple Sclerosis (MS).

Acute Ischemic Stroke: Epidemiology Forecast to 2027

  • $3,995
  • July 2018
Add to Basket Quick View Add to Saved List

A stroke occurs when blood to the brain is either blocked or interrupted by blood clots or ruptured blood vessels; this deprives the brain of oxygen and nutrients, ultimately leading to the death of brain cells. Acute ischemic stroke (AIS) occu...

Acute Ischemic Stroke: Global Drug Forecast and Market Analysis to 2027

  • $10,995
  • July 2018
Add to Basket Quick View Add to Saved List

Stroke is caused by the interruption of the blood supply to the brain, usually because a cerebral blood vessel ruptures and bleeds (hemorrhagic stroke) or is blocked by a clot (ischemic stroke), which obstructs blood flow and oxygen and nutrien...

PharmaFocus: Tauopathies–Global Market Analysis

  • $9,495
  • February 2017
Add to Basket Quick View Add to Saved List

Tauopathies are a class of more than 20 neurodegenerative diseases characterized by tau protein aggregation in the brain. There are currently no treatments approved in this therapy area and five tauopathies are attracting increasing attention f...

EpiCast Report: Multiple Sclerosis – Epidemiology Forecast to 2023

  • $3,995
  • May 2014
Add to Basket Quick View Add to Saved List

Multiple sclerosis (MS) is an inflammatory disease in which the myelin sheaths around the axons of the brain and spinal cord are damaged, leading to demyelination and a wide range of signs and symptoms. MS affects 2.5 million people worldwide e...

EpiCast Report: Acute Ischemic Stroke - Epidemiology Forecast to 2022

  • $3,995
  • September 2013
Add to Basket Quick View Add to Saved List

Stroke occurs when the blood supply to the brain is blocked or interrupted, either by blood clots or ruptured blood vessels, depriving the brain of oxygen and nutrients, ultimately leading to the death of brain cells. Stroke is a major cause of...

Epicast Report: Alzheimer’s Disease - Epidemiology Forecast to 2022

  • $3,995
  • February 2013
Add to Basket Quick View Add to Saved List

Alzheimer’s disease is the most common cause of dementia in people age 60 years and older and accounts for approximately 75% of the total dementia cases worldwide (Qui et al., 2009). The global prevalence of dementia is estimated to be 3.9% in ...

Epilepsy – Current and Future Players

  • $2,995
  • February 2013
Add to Basket Quick View Add to Saved List

GlobalData has released its pharma report, “Epilepsy - Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Epilepsy Market. The report identifies and...

EpiCast Report: Epilepsy - Epidemiology Forecast to 2022

  • $3,995
  • December 2012
Add to Basket Quick View Add to Saved List

Epilepsy affects 50 million people worldwide each year and is one of the most common neurological conditions in the world (WHO, 2005). Epilepsy is defined as a collection of brain dysfunction disorders characterized by recurrent and unpredictab...

EpiCast Report: Multiple Sclerosis - Epidemiology Forecast to 2022

  • $3,995
  • December 2012
Add to Basket Quick View Add to Saved List

Multiple sclerosis (MS) is an inflammatory disease in which the myelin sheaths around the axons of the brain and spinal cord are damaged, leading to demyelination and a wide range of signs and symptoms. MS affects 2.5 million people worldwide e...

EpiCast Report: Epilepsy - Epidemiology Forecast to 2022

  • $3,995
  • December 2012
Add to Basket Quick View Add to Saved List

Epilepsy affects 50 million people worldwide each year and is one of the most common neurological conditions in the world (WHO, 2005). Epilepsy is defined as a collection of brain dysfunction disorders characterized by recurrent and unpredictab...

International Stroke Conference 2012: Review and Analysis

  • $1,000
  • February 2012
Add to Basket Quick View Add to Saved List

GlobalData, the industry analysis specialist, has released its new conference alerts, “International Stroke Conference 2012: Review and Analysis”. The conference alert is an essential source of information and analysis on the emerging therapies...